George R. Aronoff

Learn More
Effective management of anemia due to renal failure poses many challenges to physicians. Individual response to treatment varies across patient populations and, due to the prolonged character of the therapy, changes over time. In this work, a Reinforcement Learning-based approach is proposed as an alternative method for individualization of drug(More)
Linezolid is a member of a new, unique class of synthetic antibacterial agents called oxazolidinones that are effective against gram-positive bacteria, including vancomycin-resistant organisms. We tested the hypothesis that the linezolid clearance would not be altered in subjects with renal dysfunction. Twenty-four subjects with renal function that ranged(More)
Individualization of drug delivery in treatment of chronic ailments is a challenge to the physician. Variability of response across patient population requires tailoring the dosing strategies to individual's needs. We have previously demonstrated the potential of reinforcement learning methods to support the physician in the management of anemia. In this(More)
  • 1